NanoMosaic

Diagnostic Equipment · Waltham, MA · Founded 2018 · Privately Held (backing)

Developer of a nanoneedle proteomic beta system designed to assist in proteomics. NanoMosaic is based in Waltham, MA and was founded in 2018. Its last reported valuation was $85 million in Mar 2025. It has raised $48.1 million across 3 recorded rounds; the latest was a $3 million seed round in Nov 2025.

Last reported valuation
$85.0M
Oct 2026
Priced at
—
Total raised
$48.1M
Last round
Seed Round
Nov 2025

NanoMosaic key facts

as of Oct 2026
  • Developer of a nanoneedle proteomic beta system designed to assist in proteomics.
  • NanoMosaic is valued at approximately $85.0M as of Oct 2026 (last reported valuation).
  • It has raised $48.1M across 3 recorded rounds; the latest was Seed Round ($3.0M) in Nov 2025.
  • Notable investors include Insight Partners (New York), RA Capital Management, Pura Vida Investments, Time BioVentures, 28 Capital — 6 tracked in total.
  • NanoMosaic has filed 1 Form D with the SEC, most recently Mar 2025 ($1.0M sold to 9 investors).
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$85.0M

NanoMosaic's last reported valuation, Mar 2025. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of NanoMosaic with a free account
  • ·Watch NanoMosaic: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

NanoMosaic funding rounds

3 rounds
Nov 2025Seed Round$3.0MSEC filing▮
Feb 2025Seed Round$1.0MSEC filing▮
Dec 2021Early Stage VC (Series A)$40.8M▮

NanoMosaic valuation

NanoMosaic's last reported valuation was $85 million in Mar 2025. No priced round, secondary trade or fund mark has surfaced since.

How much has NanoMosaic raised?

NanoMosaic has raised $48.1 million across 3 recorded rounds since 2021. The largest was a $40.8 million Series A in Dec 2021; the most recent was a $3 million seed round in Nov 2025.

NanoMosaic has filed 1 Form D with the SEC, most recently in Mar 2025 ($1 million sold to 9 investors).

NanoMosaic investors

6 investors are on record for NanoMosaic, including Insight Partners (New York), RA Capital Management, Pura Vida Investments and Time BioVentures. The seed round in Nov 2025 drew 6 investors.

Comparable companies

Comparable diagnostic equipment names by valuation on PrivateMarketView: Tasso ($229 million), SiPhox Health ($185 million) and AOA (Diagnostic Equipment) ($65 million).

About NanoMosaic

Developer of a nanoneedle proteomic beta system designed to assist in proteomics. The company's platform leverages the power of nanoneedles for protein detection and quantification and offers early disease detection, prognostic monitoring and biomarker discovery on a single chip, enabling the medical and healthcare industry to accelerate biomarker discovery and validation.

Industry
Diagnostic Equipment
Sector
Healthcare
HQ
Waltham, MA, United States
Founded
2018
Employees
16
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.